Prediction of radiotherapy efficacy
breast tumor
Further, the evaluation of WRAP53 as a marker predictive of radiotherapy efficacy was performed. There was a significant interaction between RNA expression of WRAP53 and radiotherapy efficacy ((A–D) Cumulative incidence of ipsilateral breast tumor recurrence (IBTR) in the presence of competing risks depending on WRAP53 and radiotherapy (RT) using protein levels from C1‐antibody (A), protein levels from C2‐antibody (B), and RNA levels of 